EDGAR Filing Documents for 0001193125-21-036239

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-21-036239

Filing Date

2021-02-10

Accepted

2021-02-10 16:05:02

Documents

153

Period of Report

2020-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d102112d10k.htm iXBRL	10-K	4842076
2	EX-10.7	d102112dex107.htm	EX-10.7	144013
3	EX-10.8	d102112dex108.htm	EX-10.8	84016
4	EX-10.9	d102112dex109.htm	EX-10.9	40253
5	EX-21	d102112dex21.htm	EX-21	6996
6	EX-23	d102112dex23.htm	EX-23	2567
7	EX-31.1	d102112dex311.htm	EX-31.1	10643
8	EX-31.2	d102112dex312.htm	EX-31.2	10515
9	EX-32	d102112dex32.htm	EX-32	4950
15	GRAPHIC	g102112g01r43.jpg	GRAPHIC	56510
16	GRAPHIC	g102112g0203043727908.jpg	GRAPHIC	1944
17	GRAPHIC	g102112page186a.jpg	GRAPHIC	16954
	Complete submission text file	0001193125-21-036239.txt		20978088

Data Files

Seq	Description	Document	Type	Size
10	XBRL TAXONOMY EXTENSION SCHEMA	teva-20201231.xsd	EX-101.SCH	137109
11	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	teva-20201231_cal.xml	EX-101.CAL	75518
12	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	teva-20201231_def.xml	EX-101.DEF	858173
13	XBRL TAXONOMY EXTENSION LABEL LINKBASE	teva-20201231_lab.xml	EX-101.LAB	927179
14	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	teva-20201231_pre.xml	EX-101.PRE	931737
18	EXTRACTED XBRL INSTANCE DOCUMENT	d102112d10k_htm.xml	XML	4452258

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131

Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267

TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)